Form 4: Health Catalyst Officer Sells Shares for Tax Obligations

Health Catalyst's Chief Tech & Product Officer, David Coy Ross, sold 3,360 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• David Coy Ross, Chief Tech & Product Officer of Health Catalyst, Inc. (HCAT), reported a transaction on September 2, 2025.
• He disposed of 3,360 shares of common stock at a price of $3.3627 per share.
• This transaction was a "sell to cover" to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• The sale was mandated by the Issuer's equity incentive plans and was not a discretionary trade by Mr. Ross.
• Following this transaction, Mr. Ross beneficially owns 204,219 shares of common stock.

Sentiment

Score: 6

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes related to RSU vesting, which is a neutral event. The underlying RSU vesting is generally positive as it indicates employee retention and achievement.

Positives

• The underlying event, the vesting of Restricted Stock Units, indicates the achievement of performance milestones or tenure by the officer.
• The transaction is a non-discretionary "sell to cover," which is a standard practice for managing tax liabilities on equity compensation.

Negatives

• A reduction in direct beneficial ownership by a key officer, even if non-discretionary, could be perceived negatively by some investors.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a small, non-discretionary sale for tax purposes. The underlying RSU vesting could be seen as positive for management alignment.
• Employees: Reflects standard equity compensation practices.

Key Dates

Recommendation

This Form 4 reports a non-discretionary 'sell to cover' transaction by a key officer to satisfy tax obligations upon RSU vesting. Such transactions are routine and do not typically indicate a change in management's outlook or a discretionary decision to reduce exposure. The underlying RSU vesting is a positive sign of employee retention and compensation. Therefore, this filing alone does not warrant a change in investment thesis, and a 'hold' recommendation is appropriate.

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, David Coy Ross, Officer Transaction